Analysen von Michael J. Yee
| 22.08.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 16.08.12 | Myriad Genetics outperform | RBC Capital Markets | |
| 20.08.12 | Myriad Genetics outperform | RBC Capital Markets | |
| 13.08.12 | Elan outperform | RBC Capital Markets | |
| 13.08.12 | Amgen outperform | RBC Capital Markets | |
| 02.08.12 | Auxilium Pharmaceuticals outperform | RBC Capital Markets | |
| 02.08.12 | Elan outperform | RBC Capital Markets | |
| 31.07.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 27.07.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 26.07.12 | Biogen outperform | RBC Capital Markets | |
| 25.07.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 25.07.12 | XenoPort outperform | RBC Capital Markets | |
| 24.07.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 23.07.12 | Elan outperform | RBC Capital Markets | |
| 23.07.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 23.07.12 | Cubist Pharmaceuticals outperform | RBC Capital Markets | |
| 23.07.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 20.07.12 | Ariad Pharmaceuticals outperform | RBC Capital Markets | |
| 16.07.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 12.07.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 11.07.12 | Biogen outperform | RBC Capital Markets | |
| 04.07.12 | Amgen outperform | RBC Capital Markets | |
| 02.07.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 29.06.12 | Acorda Therapeutics, outperform | RBC Capital Markets | |
| 29.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 22.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 22.06.12 | Elan outperform | RBC Capital Markets | |
| 22.06.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 19.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 19.06.12 | Pharmacyclics outperform | RBC Capital Markets | |
| 14.06.12 | Biogen outperform | RBC Capital Markets | |
| 08.06.12 | Elan outperform | RBC Capital Markets | |
| 04.06.12 | Ariad Pharmaceuticals outperform | RBC Capital Markets | |
| 04.06.12 | Seattle Genetics outperform | RBC Capital Markets | |
| 04.06.12 | Auxilium Pharmaceuticals outperform | RBC Capital Markets | |
| 04.06.12 | Auxilium Pharmaceuticals outperform | RBC Capital Markets | |
| 04.06.12 | ImmunoGen outperform | RBC Capital Markets | |
| 04.06.12 | Aveo Pharmaceuticals outperform | RBC Capital Markets | |
| 01.06.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 31.05.12 | Ariad Pharmaceuticals outperform | RBC Capital Markets | |
| 30.05.12 | Biogen outperform | RBC Capital Markets | |
| 30.05.12 | Sunesis Pharmaceuticals outperform | RBC Capital Markets | |
| 21.05.12 | Celgene outperform | RBC Capital Markets | |
| 18.05.12 | Seattle Genetics outperform | RBC Capital Markets | |
| 18.05.12 | Pharmacyclics outperform | RBC Capital Markets | |
| 18.05.12 | Aveo Pharmaceuticals outperform | RBC Capital Markets | |
| 18.05.12 | ArQule outperform | RBC Capital Markets | |
| 17.05.12 | Auxilium Pharmaceuticals outperform | RBC Capital Markets | |
| 10.05.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 07.05.12 | ArQule outperform | RBC Capital Markets | |